Validation of the Polish Version of the MPIIQM Questionnaire for Musicians

July 24, 2023 updated by: Anna Cygańska

Validation of the Polish Version of the Musculoskeletal Pain Intensity and Interference Questionnaire for Musicians (MPIIQM-P)

The aim of this study, originally named "Cross-Cultural Adaptation and Validation of the Musculoskeletal Pain Intensity and Interference Questionnaire for Musicians of the Polish Population (MPIIQM-P)" is the enlargement of validation of the Polish questionnaire.

Study Overview

Status

Active, not recruiting

Intervention / Treatment

Detailed Description

The aim is to determine the following psychometric properties: convergent and divergent validity, two-time reliability analysis, and exploratory factor analysis according to the recommended number of subjects of ≥45 subjects. In addition, the aim of the study is to assess the psychometric properties of the MPIIQM-P questionnaire in the online version and to compare these results with the results for the paper version obtained by Cygańska et al., 2021.

Study Type

Observational

Enrollment (Actual)

182

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Warsaw, Poland
        • Józef Piłsudski University of Physical Education in Warsaw

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

The study group consists of adult, professionally active people (women and men) who are professional orchestra musicians. The mother tongue of the respondents must be Polish.

Description

Inclusion Criteria:

  • permanent musician in an orchestra
  • Polish as a native language

Exclusion Criteria:

• freelance musician

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Professional orchestra musicians
The study group consists of adult, professionally active people (women and men) who are professional orchestra musicians. The mother tongue of the respondents must be Polish.
The intervention consists of completing the MIPIM-P, QuickDash, and Brief Pain Inventory questionnaires.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain Intensity MPIQIM
Time Frame: Baseline and change between baseline and after few (3/4) days
The Musculoskeletal Pain Intensity and Interference Questionnaire for professional orchestra Musicians of the Polish Population (MPIIQM-P); The pain intensity score can be defined as the sum of the four pain intensity items (0-40, the higher the score, the greater the pain intensity) or the mean of pain intensity score (0-10, the higher the score, the greater the pain intensity).
Baseline and change between baseline and after few (3/4) days
Pain Intensity BPI
Time Frame: Baseline and change between baseline and after few (3/4) days
In Brief Pain Inventory, subjects rates their pain intensity on a numeric rating scale from 0 to 10, the higher the score, the greater the pain intensity. The pain intensity score can be defined as the sum of the four pain intensity items (0-40, the higher the score, the greater the pain intensity). In the inventory, a score of 1-4 is defined as mild pain, a score of 5-6 as moderate pain, and a score of 7-10 as severe pain.
Baseline and change between baseline and after few (3/4) days
Pain Interference MPIQIM
Time Frame: Baseline
The Musculoskeletal Pain Intensity and Interference Questionnaire for professional orchestra Musicians of the Polish Population (MPIIQM-P); The pain interference score can be defined as the sum of the four pain interference items (0-50, the higher the score, the greater the pain interference) or the mean of pain interference score (0-10, the higher the score, the greater the pain interference).
Baseline
Pain Interference BPI
Time Frame: Baseline
In Brief Pain Inventory, subjects rate their pain interference on a numeric rating scale from 0 to 10, the higher the score, the greater the pain interference. The pain interference score can be defined as the sum of the four pain interference items (0-70, the higher the score, the greater the pain intensity) or the mean of the pain interference score (0-10, the higher the score, the greater the pain interference).
Baseline
Pain Interference
Time Frame: Baseline
In Quick Dash Questionaire, subjects rate their pain interference on a numeric rating scale from 0 to 5, the higher the score, the greater the pain interference. The pain interference score can be defined as the sum of the selected answers, divided by 4 (i.e. number of questions), subtracting 1, and multiply by 25.
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Anna K. Cygańska, Cygańska, Józef Piłsudski University of Physical Education in Warsaw

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 17, 2023

Primary Completion (Estimated)

October 28, 2023

Study Completion (Estimated)

December 1, 2023

Study Registration Dates

First Submitted

June 5, 2023

First Submitted That Met QC Criteria

June 5, 2023

First Posted (Actual)

June 15, 2023

Study Record Updates

Last Update Posted (Actual)

July 25, 2023

Last Update Submitted That Met QC Criteria

July 24, 2023

Last Verified

July 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Musculoskeletal Pain

Clinical Trials on Surveys and Questionnaires

Subscribe